Young S, Baker R, HELFENSTEIN J
Br J Cancer. 1965; 19:155-9.
PMID: 14284377
PMC: 2071415.
DOI: 10.1038/bjc.1965.18.
Daniel P, Prichard M
Br J Cancer. 1964; 13:513-20.
PMID: 14219544
PMC: 2071102.
DOI: 10.1038/bjc.1964.58.
Daniel P, Prichard M
Br J Cancer. 1963; 17:687-90.
PMID: 14111606
PMC: 2071230.
DOI: 10.1038/bjc.1963.87.
Young S, COWAN D
Br J Cancer. 1963; 17:85-9.
PMID: 14002832
PMC: 2071283.
DOI: 10.1038/bjc.1963.13.
Rivera E, Hill S, Taylor M
In Vitro. 1981; 17(2):159-66.
PMID: 6792052
DOI: 10.1007/BF02618074.
Progestin therapy of breast cancer: comparison of agents.
STOLL B
Br Med J. 1967; 3(5561):338-41.
PMID: 6029163
PMC: 1841969.
DOI: 10.1136/bmj.3.5561.338.
Effects of progesterone on 9,10-dimethyl-1,2-benzanthracene-induced mammary tumours in Sprague-Dawley rats.
JABARA A
Br J Cancer. 1967; 21(2):418-29.
PMID: 6028091
PMC: 2008112.
DOI: 10.1038/bjc.1967.48.
The effect of ovariectomy on the protein and nucleic acid content of rat mammary tumours, induced by 9, 10-dimethyl-1,2-benzanthracene.
Stevens L
Br J Cancer. 1966; 20(3):546-9.
PMID: 5950879
PMC: 2007995.
DOI: 10.1038/bjc.1966.67.
Biochemical studies on human and rat breast tissues.
Smith J, King R, Meggitt B, Allen L
Br J Cancer. 1966; 20(2):335-44.
PMID: 5944275
PMC: 2008952.
DOI: 10.1038/bjc.1966.41.
Effect of androgenisation on the development of mammary tumours in rats induced by the oral administration of 9,10-dimethyl-1,2-benzanthracene.
Kovacs K
Br J Cancer. 1965; 19(3):531-7.
PMID: 5833071
PMC: 2071333.
DOI: 10.1038/bjc.1965.65.
Endocrine differences between rats bearing simple and malignant mammary tumours induced by 9,10-dimethyl-1,2-benzanthracene.
Hamilton T, Sneddon A
Br J Cancer. 1968; 22(2):324-9.
PMID: 5660137
PMC: 2008257.
DOI: 10.1038/bjc.1968.40.
The properties of a nuclear acidic protein fraction that binds [6,7-3H]oestradiol-17beta.
King R, Gordon J, Steggles A
Biochem J. 1969; 114(3):649-57.
PMID: 4897941
PMC: 1184940.
DOI: 10.1042/bj1140649.
Effect of ovariectomy and androgen on the growth of mammary tumors induced by 7,12-dimethylbenz (alpha)-anthracene in rats.
Takahashi T, Nakamura T, Majima S
Jpn J Surg. 1973; 3(4):229-36.
PMID: 4802740
DOI: 10.1007/BF02468777.
The histogenesis of mammary tumours induced in the rat by chemical carcinogens.
Middleton P
Br J Cancer. 1965; 19(4):830-9.
PMID: 4285918
PMC: 2071390.
DOI: 10.1038/bjc.1965.96.
The effect of tumour growth on immune competence. A study of DMBA mammary carcinogenesis in the rat.
Kearney R, Hughes L
Br J Cancer. 1970; 24(2):319-27.
PMID: 4194927
PMC: 2008577.
DOI: 10.1038/bjc.1970.37.
Morphological and biological characteristics of mammary tumours induced by the direct application of DMBA powder to rat mammary glands.
Tsubura A, Shikata N, Inui T, Sakaida N, Morii S
Virchows Arch A Pathol Anat Histopathol. 1988; 414(1):1-7.
PMID: 2849834
DOI: 10.1007/BF00749731.
Histopathogenesis of 7,12-diemthylbenz(a)anthracene-induced rat mammary tumors.
Haslam S, Bern H
Proc Natl Acad Sci U S A. 1977; 74(9):4020-4.
PMID: 410031
PMC: 431827.
DOI: 10.1073/pnas.74.9.4020.
Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.
BOYLAN E, FOWLER E, Wittliff J
Br J Cancer. 1977; 35(5):602-9.
PMID: 405032
PMC: 2025488.
DOI: 10.1038/bjc.1977.94.
Paramagnetic changes in cancer: DMBA-induced tumours studied in non-lyophilized and lyophilized tissues.
Gutierrez P, Swartz H, Wilkinson E
Br J Cancer. 1979; 39(3):330-6.
PMID: 223619
PMC: 2009880.
DOI: 10.1038/bjc.1979.57.
